Edition:
India

Fate Therapeutics Announces Pricing Of Public Offering Of Common Stock

Dec 13 (Reuters) - Fate Therapeutics Inc ::FATE THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 9.53 MILLION COMMON SHARES PRICED AT $4.20PER SHARE.

Wednesday, 13 Dec 2017

MabVax Completes Enrollment In Initial Cohort Of Its Cancer Drug

Dec 13 (Reuters) - MabVax Therapeutics Holdings Inc ::MABVAX THERAPEUTICS ANNOUNCES COMPLETION OF ENROLLMENT AND DOSING IN INITIAL COHORT OF MVT-1075 RADIOIMMUNOTHERAPY PHASE 1 TRIAL FOR THE TREATMENT OF PANCREATIC, COLON AND LUNG CANCERS.MABVAX THERAPEUTICS HOLDINGS INC - PLANS TO REPORT INTERIM...

Wednesday, 13 Dec 2017

Iovance Biotherapeutics Announces Manufacturing Decision, Provides Clinical Updates

Dec 13 (Reuters) - Iovance Biotherapeutics Inc ::IOVANCE BIOTHERAPEUTICS ANNOUNCES MANUFACTURING DECISION, PROVIDES CLINICAL UPDATES AND HIGHLIGHTS PIPELINE EXPANSION AT ANALYST DAY 2017.IOVANCE BIOTHERAPEUTICS - SELECTED ITS GEN 2 MANUFACTURING PROCESS FOR ALL THREE PHASE 2 TRIALS, ALL FUTURE TIL...

Wednesday, 13 Dec 2017

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.